Huan Yan Selected Research

sodium-bile acid cotransporter

10/2016	DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
10/2016	Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
1/2015	Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
3/2014	Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
7/2013	Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.
6/2013	Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.
11/2012	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
11/2012	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huan Yan Research Topics

Disease

23	Neoplasms (Cancer) 10/2022 - 01/2016
12	Infections 01/2022 - 06/2013
9	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 02/2016
8	Virus Diseases (Viral Diseases) 01/2020 - 11/2012
7	Hepatitis B 09/2015 - 11/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2017
4	Carcinogenesis 05/2020 - 01/2017
3	Inflammation (Inflammations) 02/2022 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2020
3	Wounds and Injuries (Trauma) 10/2017 - 01/2013
2	Adenocarcinoma 01/2022 - 11/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2017
2	Cholangiocarcinoma 01/2021 - 05/2020
2	Reperfusion Injury 01/2020 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 04/2015
2	Papillary Thyroid Cancer 10/2018 - 01/2018
2	Hypoxia (Hypoxemia) 09/2018 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2017 - 01/2013
2	Vascular System Injuries 05/2016 - 01/2016
1	Edema (Dropsy) 02/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	COVID-19 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Glioma (Gliomas) 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Anemia 01/2021
1	Professional Burnout 01/2020
1	Severe Fever with Thrombocytopenia Syndrome 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Occupational Stress 01/2020
1	Craniocerebral Trauma (Head Injury) 01/2020
1	Epilepsy (Aura) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Drug Resistant Epilepsy 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Neuroinflammatory Diseases 01/2019

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2013
8	sodium-bile acid cotransporterIBA 10/2016 - 11/2012
7	Antiviral Agents (Antivirals)IBA 01/2021 - 03/2014
6	Long Noncoding RNAIBA 01/2021 - 09/2018
5	Pharmaceutical PreparationsIBA 10/2020 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
4	Amino Acids FDA Link 10/2016 - 11/2012
4	Taurocholic Acid (Sodium Taurocholate)IBA 04/2015 - 07/2013
3	Biological ProductsIBA 10/2022 - 10/2017
3	SaponinsIBA 01/2021 - 01/2016
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
3	SurvivinIBA 12/2019 - 02/2016
3	Peptides (Polypeptides)IBA 01/2019 - 06/2013
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 11/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 12/2018
2	Benzene (Benzole)IBA 01/2020 - 01/2020
2	AsbestosIBA 01/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
2	UbiquitinIBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 04/2018 - 01/2018
2	IntegrinsIBA 01/2018 - 10/2017
2	CollagenIBA 10/2017 - 01/2013
2	RNA (Ribonucleic Acid)IBA 10/2016 - 04/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2015 - 03/2014
1	Catechin (Z 7300)IBA 02/2022
1	LipopolysaccharidesIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Interleukin-10 (Interleukin 10)IBA 02/2022
1	ZymosanIBA 02/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	VaccinesIBA 11/2021
1	pembrolizumabIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	NivolumabIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Type III Secretion SystemsIBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2020
1	Coal (Coals)IBA 01/2020
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2020
1	Doublecortin-Like KinasesIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	GlycosidesIBA 01/2020
1	DioxygenasesIBA 01/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	CytosineIBA 01/2020
1	SB 203580IBA 01/2020
1	ChromatinIBA 01/2019
1	Carbon MonoxideIBA 01/2019
1	TransducinIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2014
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
3	Immunotherapy 01/2022 - 01/2021
2	Thyroidectomy 01/2019 - 01/2018
1	Radiotherapy 01/2021
1	Intraperitoneal Injections 01/2021